| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | IPRO2 CGM SYSTEM WITH ENLITE SENSOR |
| Generic Name | Sensor, glucose, invasive |
| Applicant | Medtronic Minimed 18000 Devonshire St. Northridge, CA 91325 |
| PMA Number | P150029 |
| Supplement Number | S011 |
| Date Received | 07/17/2017 |
| Decision Date | 08/16/2017 |
| Product Codes |
MDS OZO |
| Advisory Committee |
Clinical Chemistry |
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Changes to the test method and acceptance criteria for the glucose layer membrane solution release testing that is performed for use of the solution in Enlite Sensor fabrication. The Enlite Sensor is a component of the MiniMed 530G System, MiniMed 630G System, Paradigm Real-Time Revel System, and iPro2 Continuous Glucose Monitoring System. |
|
|